✦ LIBER ✦

Plasma profiles following single, oral, and rectal doses of phenylbutazone in healthy volunteers

✍ Scribed by V. A. John; J. P. Monk; J. Hubbard; W. Theobald

Publisher: John Wiley and Sons
Year: 1983
Tongue: English
Weight: 235 KB
Volume: 4
Category: Article
ISSN: 0142-2782
DOI: 10.1002/bdd.2510040112

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Single-dose bioavailability of oral and

Single-dose bioavailability of oral and intramuscular thiocolchicoside in healthy volunteers

✍ P. Sandouk; M. Bouvier d'Yvoire; P. Chretien; J. P. Tillement; J. M. Scherrmann 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 2 views

A single dose of 8 mg of thiocolchicoside was administered to 12 healthy volunteers according to a Latin square design, either as tablets (reference), oral solution, or intramuscular injection. Serum thiocolchicoside concentrations showed an absorption phase followed by a biexponential decay with a

Single dose pharmacokinetics and bioavai

Single dose pharmacokinetics and bioavailability of nevirapine in healthy volunteers

✍ Michael J. Lamson; John P. Sabo; Thomas R. Macgregor; Joseph W. Pav; Lois Rowlan 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 2 views

The results of two randomized, single-dose, crossover bioavailability studies are presented which describe the pharmacokinetics and oral bioavailability of nevirapine, a novel nonnucleoside antiretroviral drug. In the first study 12 healthy male volunteers received nevirapine 15 mg via short-term i.

Single- and multiple-dose pharmacokineti

Single- and multiple-dose pharmacokinetics of oral dolasetron and its active metabolites in healthy volunteers: part 2

✍ Dan C. Dimmitt; Youn Sung Choo; Lorene A. Martin; Thangam Arumugham; William F. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 2 views

The single-and multiple-dose pharmacokinetics and dose-proportionality of oral dolasetron and its active metabolites over the therapeutic dose range was investigated in 18 healthy men. In an open-label, randomized, complete three-way crossover design, each subject received three separate doses: 50,

Pharmacokinetics of terbinafine and of i

Pharmacokinetics of terbinafine and of its five main metabolites in plasma and urine, following a single oral dose in healthy subjects

✍ H. Humbert; M. D. Cabiac; J. Denouël; S. Kirkesseli 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 482 KB 👁 2 views

The single dose pharmacokinetics and saf

The single dose pharmacokinetics and safety of deramciclane in healthy male volunteers

✍ Harri Kanerva; Olavi Kilkku; Esa Heinonen; Antti Helminen; Juha Rouru; Simo Tarp 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB 👁 2 views

The pharmacokinetics and tolerability of a new putative non-benzodiazepine type anxiolytic compound deramciclane was studied in two consecutive studies. An open dose-escalation design was used to study doses from 0.2 to 50 mg in 18 healthy male volunteers. In the second study doses from 50 to 150 mg

Pharmacokinetics of fluvoxamine maleate

Pharmacokinetics of fluvoxamine maleate after increasing single oral doses in healthy subjects

✍ M. H. De Vries; J. Van Harten; P. Van Bemmel; M. Raghoebar 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB 👁 2 views

The pharmacokinetics of fluvoxamine after single oral administration of 25, 50, and 100mg fluvoxamine maleate was studied in a three-way cross-over study in 12 healthy male subjects. Fluvoxamine was administered orally in a solution. For doseproportionality, AUC, and C,-dose relationships were evalu